
Asp Isotopes (ASPI) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Mar 2025Income Metrics
Revenue
1.1M
Gross Profit
326.8K
29.67%
Operating Income
-8.0M
-721.89%
Net Income
-8.5M
-768.10%
EPS (Diluted)
$-0.12
Balance Sheet Metrics
Total Assets
90.9M
Total Liabilities
45.1M
Shareholders Equity
45.7M
Debt to Equity
0.99
Cash Flow Metrics
Operating Cash Flow
-7.2M
Free Cash Flow
-5.5M
Revenue & Profitability Trend
Asp Isotopes Income Statement From 2022 to 2024
Metric | 2024 | 2023 | 2022 |
---|---|---|---|
Revenue | 4.1M | 433.0K | 0 |
Cost of Goods Sold | 2.5M | 294.1K | 0 |
Gross Profit | 1.6M | 139.0K | 0 |
Gross Margin % | 38.6% | 32.1% | 0.0% |
Operating Expenses | |||
Research & Development | 3.1M | 764.6K | 1.3M |
Selling, General & Administrative | 24.8M | 15.4M | 3.8M |
Other Operating Expenses | - | - | - |
Total Operating Expenses | 28.0M | 16.2M | 5.1M |
Operating Income | -26.4M | -16.0M | -5.1M |
Operating Margin % | -635.9% | -3,704.6% | 0.0% |
Non-Operating Items | |||
Interest Income | 1.2M | 9.1K | 3.4K |
Interest Expense | 258.9K | 118.5K | 0 |
Other Non-Operating Income | -6.9M | -148.8K | 150.5K |
Pre-tax Income | -32.3M | -16.3M | -4.9M |
Income Tax | 111.4K | -6.1K | 0 |
Effective Tax Rate % | 0.0% | 0.0% | 0.0% |
Net Income | -32.4M | -16.3M | -4.9M |
Net Margin % | -782.4% | -3,762.9% | 0.0% |
Key Metrics | |||
EBITDA | -31.7M | -16.2M | -4.9M |
EPS (Basic) | $-0.63 | $-0.49 | $-0.18 |
EPS (Diluted) | $-0.63 | $-0.49 | $-0.18 |
Basic Shares Outstanding | 55671805 | 33066708 | 26793748 |
Diluted Shares Outstanding | 55671805 | 33066708 | 26793748 |
Income Statement Trend
Asp Isotopes Balance Sheet From 2021 to 2024
Metric | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Assets | ||||
Current Assets | ||||
Cash & Equivalents | 61.9M | 7.9M | 2.4M | 3.0M |
Short-term Investments | - | - | - | - |
Accounts Receivable | 706.9K | 216.5K | 0 | - |
Inventory | 65.7K | - | - | - |
Other Current Assets | 3.1M | 1.7M | 913.0K | 267.6K |
Total Current Assets | 65.7M | 10.5M | 3.3M | 3.2M |
Non-Current Assets | ||||
Property, Plant & Equipment | 1.1M | 1.3M | 853.9K | 933.1K |
Goodwill | 6.3M | 6.5M | 0 | - |
Intangible Assets | - | - | - | - |
Long-term Investments | - | - | - | - |
Other Non-Current Assets | 2.0M | 1.8M | 139.6K | - |
Total Non-Current Assets | 28.6M | 17.0M | 9.2M | 3.9M |
Total Assets | 94.3M | 27.5M | 12.5M | 7.1M |
Liabilities | ||||
Current Liabilities | ||||
Accounts Payable | 1.0M | 1.1M | 1.4M | 59.7K |
Short-term Debt | 1.6M | 868.9K | 79.8K | 85.0K |
Current Portion of Long-term Debt | - | - | - | - |
Other Current Liabilities | 1.3M | 1.5M | 140.5K | 116.2K |
Total Current Liabilities | 7.1M | 5.7M | 1.9M | 303.4K |
Non-Current Liabilities | ||||
Long-term Debt | 36.1M | 1.3M | 742.4K | 841.6K |
Deferred Tax Liabilities | 0 | 110.6K | 0 | - |
Other Non-Current Liabilities | - | 1.7M | - | - |
Total Non-Current Liabilities | 36.1M | 3.0M | 742.4K | 841.6K |
Total Liabilities | 43.2M | 8.7M | 2.7M | 1.1M |
Equity | ||||
Common Stock | 720.7K | 489.2K | 359.1K | 206.5K |
Retained Earnings | -56.2M | -23.8M | -7.6M | -2.6M |
Treasury Stock | - | - | - | - |
Other Equity | - | - | - | - |
Total Shareholders Equity | 51.2M | 18.8M | 9.8M | 6.0M |
Key Metrics | ||||
Total Debt | 37.7M | 2.1M | 822.2K | 926.6K |
Working Capital | 58.7M | 4.8M | 1.4M | 2.9M |
Balance Sheet Composition
Asp Isotopes Cash Flow Statement From 2022 to 2024
Metric | 2024 | 2023 | 2022 |
---|---|---|---|
Operating Activities | |||
Net Income | -32.4M | -16.3M | -4.9M |
Depreciation & Amortization | 471.4K | 37.4K | 0 |
Stock-Based Compensation | 8.6M | 8.7M | 2.0M |
Working Capital Changes | -2.2M | 854.9K | 386.8K |
Operating Cash Flow | -23.3M | -5.9M | -2.4M |
Investing Activities | |||
Capital Expenditures | -11.4M | -2.3M | -4.5M |
Acquisitions | 0 | -121.8K | 0 |
Investment Purchases | - | - | - |
Investment Sales | - | - | - |
Investing Cash Flow | -11.4M | -2.5M | -4.5M |
Financing Activities | |||
Share Repurchases | - | - | - |
Dividends Paid | - | - | - |
Debt Issuance | 25.9M | - | - |
Debt Repayment | -713.2K | -706.8K | -13.0K |
Financing Cash Flow | 76.1M | 12.7M | 6.6M |
Free Cash Flow | -28.1M | -7.7M | -7.4M |
Net Change in Cash | 41.4M | 4.4M | -268.2K |
Cash Flow Trend
Asp Isotopes Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
-14.17
Forward P/E
-59.53
Price to Book
15.14
Price to Sales
185.28
PEG Ratio
-59.53
Profitability Ratios
Profit Margin
38.60%
Operating Margin
-721.89%
Return on Equity
-115.46%
Return on Assets
-26.14%
Financial Health
Current Ratio
7.21
Debt to Equity
84.08
Beta
3.38
Per Share Data
EPS (TTM)
$-0.59
Book Value per Share
$0.59
Revenue per Share
$0.07
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
aspi | 816.3M | -14.17 | 15.14 | -115.46% | 38.60% | 84.08 |
Dow | 15.4B | 75.93 | 0.90 | -4.74% | -2.35% | 97.39 |
Celanese | 5.3B | 6.78 | 1.02 | -24.98% | -16.54% | 234.12 |
Huntsman | 1.6B | 46.18 | 0.54 | -2.19% | -2.63% | 74.27 |
Rex American | 839.7M | 15.79 | 1.57 | 11.48% | 8.86% | 4.23 |
Lsb Industries | 543.1M | 210.50 | 1.10 | -6.51% | -6.16% | 98.92 |
Financial data is updated regularly. All figures are in the company's reporting currency.